170 related articles for article (PubMed ID: 31943232)
21. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results.
Li Z; Shan F; Wang Y; Li S; Jia Y; Zhang L; Yin D; Ji J
Surg Endosc; 2016 Oct; 30(10):4265-71. PubMed ID: 27287914
[TBL] [Abstract][Full Text] [Related]
22. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort.
Jiang Q; Liu W; Zeng X; Zhang C; Du Y; Zeng L; Yin Y; Fan J; Yang M; Tao K; Zhang P
Front Immunol; 2023; 14():1122121. PubMed ID: 37215127
[TBL] [Abstract][Full Text] [Related]
25. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
26. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
[TBL] [Abstract][Full Text] [Related]
27. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
[TBL] [Abstract][Full Text] [Related]
28. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
30. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.
Jin LX; Sanford DE; Squires MH; Moses LE; Yan Y; Poultsides GA; Votanopoulos KI; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine EA; Winslow E; Saunders N; Spolverato G; Colditz GA; Maithel SK; Fields RC
Ann Surg Oncol; 2016 Aug; 23(8):2398-408. PubMed ID: 27006126
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Wang LB; Teng RY; Jiang ZN; Hu WX; Dong MJ; Yuan XM; Chen WJ; Jin M; Shen JG
J Surg Oncol; 2012 Mar; 105(3):293-6. PubMed ID: 21882201
[TBL] [Abstract][Full Text] [Related]
32. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Wu Q; Ren H; Ji JF
World J Surg Oncol; 2011 Sep; 9():110. PubMed ID: 21942969
[TBL] [Abstract][Full Text] [Related]
33. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.
Wang L; Wang XA; Hao JQ; Zhang LN; Li ML; Wu XS; Weng H; Lv WJ; Zhang WJ; Chen L; Xiang HG; Lu JH; Liu YB; Dong P
World J Gastroenterol; 2015 Dec; 21(47):13316-24. PubMed ID: 26715815
[TBL] [Abstract][Full Text] [Related]
35. Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
Leung K; Sun Z; Nussbaum DP; Adam MA; Worni M; Blazer DG
Surg Oncol; 2017 Sep; 26(3):324-330. PubMed ID: 28807254
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials.
Coccolini F; Nardi M; Montori G; Ceresoli M; Celotti A; Cascinu S; Fugazzola P; Tomasoni M; Glehen O; Catena F; Yonemura Y; Ansaloni L
Int J Surg; 2018 Mar; 51():120-127. PubMed ID: 29413875
[TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy.
Liu L; Wang C; Li F; Zhang X; Cheng X; Lin S; Liu Y; Yang C; Li W
Sci Rep; 2022 Jun; 12(1):10384. PubMed ID: 35726012
[TBL] [Abstract][Full Text] [Related]
38. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
39. Significance of neoadjuvant downstaging in gastric adenocarcinoma.
Prasad P; Sivaharan A; Navidi M; Fergie BH; Griffin SM; Phillips AW
Surgery; 2022 Aug; 172(2):593-601. PubMed ID: 35400501
[TBL] [Abstract][Full Text] [Related]
40. Comparison of neoadjuvant versus upfront surgery for treatment of locally advanced gastric cancer.
Omarov N; Uymaz DS; Gurbuz B; Selcukbiricik F; Cigtaskin O; Yesilsoy M; Ozoran E; Balik E; Bugra D
Ann Ital Chir; 2023; 94():569-579. PubMed ID: 37724662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
